Varenicline, a daily anti-smoking pill, is now being rolled out through the UK's health service as a potential game-changer against smoking addiction.
The drug, prescribed for 12 weeks, aims to combat smoking, which still affects nearly one in five people in Ireland.
Previously branded as Champix, Varenicline was withdrawn in 2021 due to impurities, but Teva has developed a new improved generic version for future access.
Doctors will need to prescribe Varenicline, which reflects a growing trend in developing pharmaceuticals specifically to help smokers in their quit journeys.
Collection
[
|
...
]